Correlation Between Heron Therapeuti and Intellipharmaceutics

Can any of the company-specific risk be diversified away by investing in both Heron Therapeuti and Intellipharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Heron Therapeuti and Intellipharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Heron Therapeuti and Intellipharmaceutics International, you can compare the effects of market volatilities on Heron Therapeuti and Intellipharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Heron Therapeuti with a short position of Intellipharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Heron Therapeuti and Intellipharmaceutics.

Diversification Opportunities for Heron Therapeuti and Intellipharmaceutics

0.15

Correlation Coefficient

Heron Therapeuti  Intellipharmaceutics

Average diversification

The 3 months correlation between Heron and Intellipharmaceutics is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Heron Therapeuti and Intellipharmaceutics Internati in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intellipharmaceutics and Heron Therapeuti is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Heron Therapeuti are associated (or correlated) with Intellipharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intellipharmaceutics has no effect on the direction of Heron Therapeuti i.e., Heron Therapeuti and Intellipharmaceutics go up and down completely randomly.

Pair Corralation between Heron Therapeuti and Intellipharmaceutics

If you would invest  191.00  in Heron Therapeuti on October 27, 2024 and sell it today you would lose (8.00) from holding Heron Therapeuti or give up 4.19% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	1.67%
Values	Daily Returns

Heron Therapeuti  vs.  Intellipharmaceutics Internati

Heron Therapeuti

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Heron Therapeuti are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Heron Therapeuti showed solid returns over the last few months and may actually be approaching a breakup point.

Intellipharmaceutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Intellipharmaceutics International has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable forward indicators, Intellipharmaceutics is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Heron Therapeuti and Intellipharmaceutics

The main advantage of trading using opposite Heron Therapeuti and Intellipharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Heron Therapeuti position performs unexpectedly, Intellipharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intellipharmaceutics will offset losses from the drop in Intellipharmaceutics' long position.

The idea behind Heron Therapeuti and Intellipharmaceutics International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.